» Articles » PMID: 36839254

What Should I Eat? Dietary Recommendations for Patients with Inflammatory Bowel Disease

Overview
Journal Nutrients
Date 2023 Feb 25
PMID 36839254
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory bowel disease (IBD) is a chronic disorder thought to be caused by enteric inflammation in a genetically susceptible host. Although the pathogenesis of IBD is largely unknown, it is widely accepted that dietary components play an important role. Human and animal-based studies have explored the role of various dietary components such as meat, artificial sweeteners and food additives in causing enteric inflammation. Several diets have also been studied in patients with IBD, specifically their role in the induction or maintenance of remission. The most well-studied of these include exclusive enteral nutrition and specific carbohydrate diet. A diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols), typically prescribed for patients with irritable bowel syndrome, has also been studied in a specific subgroup of patients with IBD. In this review, we describe the current evidence on how various dietary components can induce enteric and colonic inflammation, and the clinical-epidemiological evidence exploring their role in predisposing to or protecting against the development of IBD. We also discuss several special diets and how they affect clinical outcomes in IBD patients. Based on the available evidence, we provide guidance for patients and clinicians managing IBD regarding the best practice in dietary modifications.

Citing Articles

Adjunct Therapies to Standard Care for IBS and IBD Patients: Digestive Symptoms Improvement and Quality of Life Optimization.

Traynard V Nutrients. 2024; 16(22).

PMID: 39599713 PMC: 11597149. DOI: 10.3390/nu16223927.


Nutritional Profile, Disease Severity, and Quality of Life of Patients with Inflammatory Bowel Disease: A Case-Control Study.

Sayegh L, Haddad F, Bou Jaoude L, Fakhoury-Sayegh N, Heraoui G, Nasrallah Z Nutrients. 2024; 16(12).

PMID: 38931181 PMC: 11206244. DOI: 10.3390/nu16121826.


The association between circulating leukocytes and inflammatory bowel disease: a two-sample Mendelian randomization study.

Tian L, Yang X, Zheng Y, Peng C Front Med (Lausanne). 2024; 11:1399658.

PMID: 38860205 PMC: 11163050. DOI: 10.3389/fmed.2024.1399658.


Influential factors on disease activity in Crohn's disease and their Roc curve evaluation: a cross-sectional study.

Wang J, Tong S, Lu B BMC Gastroenterol. 2024; 24(1):126.

PMID: 38570741 PMC: 10993542. DOI: 10.1186/s12876-024-03211-0.


Natural Products and Health.

Bartkowiak-Wieczorek J, Madry E Nutrients. 2024; 16(3).

PMID: 38337699 PMC: 10856951. DOI: 10.3390/nu16030415.


References
1.
Chiba M, Abe T, Tsuda H, Sugawara T, Tsuda S, Tozawa H . Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet. World J Gastroenterol. 2010; 16(20):2484-95. PMC: 2877178. DOI: 10.3748/wjg.v16.i20.2484. View

2.
Larmonier C, Midura-Kiela M, Ramalingam R, Laubitz D, Janikashvili N, Larmonier N . Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease. Inflamm Bowel Dis. 2010; 17(2):503-15. PMC: 2958245. DOI: 10.1002/ibd.21391. View

3.
Bhattacharyya S, Shumard T, Xie H, Dodda A, Varady K, Feferman L . A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity. Nutr Healthy Aging. 2017; 4(2):181-192. PMC: 5389019. DOI: 10.3233/NHA-170023. View

4.
Tinsley A, Ehrlich O, Hwang C, Issokson K, Zapala S, Weaver A . Knowledge, Attitudes, and Beliefs Regarding the Role of Nutrition in IBD Among Patients and Providers. Inflamm Bowel Dis. 2016; 22(10):2474-81. DOI: 10.1097/MIB.0000000000000901. View

5.
Obih C, Wahbeh G, Lee D, Braly K, Giefer M, Shaffer M . Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition. 2015; 32(4):418-25. DOI: 10.1016/j.nut.2015.08.025. View